Glenmark Life Sciences IPO to hit the market on 27 July 2021 and closes on 29 July 2021. The company plans to raise Rs.15515 crore through the initial public offerings. Glenmark Life Sciences is an API arm of Glenn Mark Pharma, a leading drug maker. They are one of the leading developer and manufacturer of Active Pharmaceutical Ingredients (APIs). They are making high-quality drugs by unlocking the possibilities of science. They created the strong relationship with leading pharmaceutical companies that have helped us expand our product offerings and geographic reach. They have 120 API in their catalogue. They supply their API to 540 pharma companies in India and overseas. They export their products in Europe, Latin America, North America, Japan, and the rest of the world. Check out Glenmark Life Sciences IPO details.
Important Details:
According to the DRHP, the proceeds from the IPO will be used for:
Glenmark Life Sciences IPO Date & Price Band
Karvy Fintech Private Limited)
Selenium Tower-B
Plot No-31 and 32, Financial District
Nanakramguda, Serilingampally
Hyderabad, Rangareddi 500032
Telangana, India
Tel: +91 40 6716 2222
E-mail: glenmark.ipo@kfintech.com
Investor Grievance E-mail: einward.ris@kfintech.com
Website: www.kfintech.com
Contact Person: M Murali Krishna
SEBI Registration No.: INR000000221
- Payment of outstanding purchase consideration to the promoter for the spin-off of the API businessb)
- Funding capital expenditure requirements
- General corporate purposes
How to apply in Share Holder Quota:
If you want to apply Glenmark Life Sciences IPO in the share holder quota, you should buy at least 1 share of Glenmark Pharma. It should be in your demat account when the company announce their IPO date or before RHP.
Note: According to RHP there is no Share Holders Quota.
Glenmark Life Sciences IPO Date & Price Band
| IPO Open: | 27 July 2021 |
| IPO Close: | 29 July 2021 |
| IPO Size: | Approx Rs.1514 Crores |
| Fresh Issue: | Approx Rs.1060 Crores |
| Offer for Sale: | Approx Rs.454 Crores, 63,00,000 Shares |
| Face Value: | Rs.2 Per Equity Share |
| Price Band: | Rs.695 to Rs.720 Per Share |
| Listing on: | BSE & NSE |
| Retail Portion: | 35% |
| Equity: | - Shares |
Glenmark Life Sciences IPO Market Lot
The Glenmark Life Sciences IPO minimum market lot is 20 shares with Rs.14,400 application amount. The retail investors can apply up-to 13 lots with 260 shares or Rs.187,200 amount.
| Minimum Lot Size: | Minimum 20 Shares |
| Minimum Amount: | Rs.14,400 |
| Maximum Lot Size: | Maximum 260 Shares |
| Maximum Amount: | Rs.187,200 |
Glenmark Life Sciences IPO Date, Time Table, Allotment & Listing
The Glenmark Life Sciences IPO date is 27 July 2021 and the IPO close date is 29 July 2021. The allotment date is 03 August 2021 and the IPO may list on 06 August 2021.
| Basis of Allotment: | 27 July 2021 |
| Basis of Allotment: | 29 July 2021 |
| Basis of Allotment: | 03 August 2021 |
| Refunds: | 04 August 2021 |
| Credit to Demat Account: | 05 August 2021 |
| Listing Date: | 06 August 2021 |
Glenmark Life Sciences IPO Form
How to apply the Glenmark Life Sciences IPO? You can apply Glenmark Life Sciences IPO via ASBA available in your bank account. Just go to the online bank login and apply via your bank account by selecting the Glenmark Life Sciences IPO in the Invest section. The other option you can apply Glenmark Life Sciences IPO via IPO forms download via NSE and BSE. Check out the Glenmark Life Sciences forms - click NSE Forms & BSE Forms blank IPO forms download, fill and submit in your bank or with your broker.
Glenmark Life Sciences Company Financial Report
| Rs. in Crores | |||||
| Revenue | Expenses | PAT | |||
| 2018 | 0.25 | 0.26 | -0.43 | ||
| 2019 | 886.87 | 658.59 | 195.59 | ||
| 2020 | 1549.30 | 1128.24 | 313.10 | ||
| 2021 9M | 1418.47 | 1088.15 | 246.90 | ||
Subscriptions
| Category | Shares Offered | Day 1 | Day 2 | Day 3 |
| QIB | 42,42,379 | 0.00 | 1.39 | 36.97 |
| NII | 32,32,770 | 0.85 | 3.40 | 122.54 |
| Retail | 75,43,130 | 5.17 | 9.28 | 14.63 |
| Total | 1,50,18,279 | 2.78 | 5.78 | 44.17 |
Company Promoters
- Glenmark Pharmaceuticals Limited
Glenmark Life Sciences IPO Registrar
KFin Technologies Private Limited (Formerly known asKarvy Fintech Private Limited)
Selenium Tower-B
Plot No-31 and 32, Financial District
Nanakramguda, Serilingampally
Hyderabad, Rangareddi 500032
Telangana, India
Tel: +91 40 6716 2222
E-mail: glenmark.ipo@kfintech.com
Investor Grievance E-mail: einward.ris@kfintech.com
Website: www.kfintech.com
Contact Person: M Murali Krishna
SEBI Registration No.: INR000000221
Note: Glenmark Life Sciences IPO allotment status on KFintech website allotment URL.
Click Here
Registered Office:
Plot No. 170-172, Chandramouli Industrial Estate,
Mohol Bazarpeth, Solapur 413 213, Maharashtra
Corporate Office:
Glenmark House, B. D. Sawant Marg,
Andheri (East), Mumbai 400099,
Maharashtra, India
Tel: +912189 234456/ +912189 234246
Website: www.glenmarklifesciences.com
Contact Person: Rudalf Corriea
(Company Secretary and Compliance Officer)
E-mail: complianceofficer@glenmarklifesciences.com
Glenmark Life Sciences IPO Lead Managers
- Kotak Mahindra Capital Company Limited
- BofA Securities India Limited
- Goldman Sachs (India) Securities Private Limited
- DAM Capital Advisors Limited
- BOB Capital Markets Limited
- SBI Capital Markets Limited
Company Address
Glenmark Life Sciences LimitedRegistered Office:
Plot No. 170-172, Chandramouli Industrial Estate,
Mohol Bazarpeth, Solapur 413 213, Maharashtra
Corporate Office:
Glenmark House, B. D. Sawant Marg,
Andheri (East), Mumbai 400099,
Maharashtra, India
Tel: +912189 234456/ +912189 234246
Website: www.glenmarklifesciences.com
Contact Person: Rudalf Corriea
(Company Secretary and Compliance Officer)
E-mail: complianceofficer@glenmarklifesciences.com
No comments:
Post a Comment